Epstein Barr Virus External Quality Assessment

The RIQAS Epstein Barr Virus (infectious mononucleosis) EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.

  • Liquid ready-to-use
  • 100% human Plasma
  • Quarterly reporting (3 samples per quarterly distribution)
  • Submit results and view reports online via RIQAS.Net
  • Suitable for both quantitative and qualitative methods of analysis

Not accredited to ISO/IEC 17043

Cat NoKit SizeFrequencyCycle StartAnalytes 
RQ91533 x 1ml
(samples shipped 4 times per year)
Quarterly reporting
(1 x 12 month cycle)
June3

[ddownload class="button tiny secondary" id="4291" text="Enrolment Document"]

[ddownload class="button tiny secondary" id="4292" text="Method Questionnaire"]

[ddownload class="button tiny secondary" id="2976" text="Instrument & Reagent Codes"]


Parameters

  • Anti-EBNA IgG
  • Anti-EBV VCA IgG
  • Anti-EBV VCA IgM
Clinical Laboratory Survey